Amarin | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.29B 562M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
AstraZeneca USD 3.59B 1.96B 2025-03
DBV Technologies USD 6.24M 1.32M 2024-09
GlaxoSmithKline GBP 2.06B 603M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12



Amarin 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.